Approval · Notice of Compliance 7344 · 2005
DIOVAN: Notice of Compliance 7344
Issued September 1, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7344
- Date
- September 1, 2005
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New lower 40 mg strength and new indication for treatment following myocardial infarction
- Therapeutic class
- Angiotensin ii at1 receptor blocker
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIOVAN | 02270528 | Marketed |
| DIOVAN | Not yet assigned | — |